

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
I-Adalimumab-ryvk iyisihlobo se-biosimilar somuthi i-adalimumab, osiza ukwelapha izimo ze-autoimmune ngokuthulisa amasosha omzimba asebenza ngokweqile. Lo muthi ongajovwa usebenza ngokuvimba iphrotheni ethile emzimbeni wakho ebangela ukuvuvukala, unikeza ukukhululeka ezimweni ezinjenge-rheumatoid arthritis, i-psoriasis, kanye nesifo samathumbu esivuvukalayo.
Ungase uzibuze ukuthi yini eyenza lo muthi uhluke ku-adalimumab yasekuqaleni. Ingxenye ethi "ryvk" imane nje ikhomba ukuthi lokhu kuyisihlobo se-biosimilar, okusho ukuthi cishe iyafana neyasekuqaleni kodwa yenziwe ngumkhiqizi ohlukile, ngokuvamile okwenza ibizeke kakhulu ngenkathi inikeza izinzuzo ezifanayo zokwelapha.
I-Adalimumab-ryvk ngumuthi we-biosimilar olingisa isenzo se-adalimumab, umuthi we-biologic osetshenziselwa ukwelapha izimo ezihlukahlukene ze-autoimmune. Ingaphansi kohlobo lwemithi ebizwa ngokuthi ama-TNF (tumor necrosis factor) blockers, asebenza ngokucindezela izingxenye ezithile zamasosha akho omzimba ezibangela ukuvuvukala.
Lo muthi unikezwa njengomjovo ongaphansi kwesikhumba, okusho ukuthi ujovwa ngaphansi kwesikhumba, ngendlela efanayo nabantu abanesifo sikashukela abajova i-insulin. Umjovo ngokuvamile unikezwa ethangeni lakho, esiswini, noma engalweni engenhla, futhi iziguli eziningi zifunda ukuzijova ekhaya.
Imithi ye-Biosimilar efana ne-adalimumab-ryvk ihlolwa ngokuqinile ukuze kuqinisekiswe ukuthi isebenza ngempumelelo njengomuthi wokuqala. Kufanele ihlangabezane nezindinganiso ezifanayo zokuphepha nokusebenza kahle, ikunikeze ukuzethemba ukuthi uthola ukwelashwa okuseqophelweni eliphezulu ngesimo sakho.
I-Adalimumab-ryvk iphatha izimo eziningi ze-autoimmune lapho amasosha akho omzimba ehlasela ngokungaqondile izicubu ezinempilo emzimbeni wakho. Udokotela wakho angase akunikeze lo muthi uma isimo sakho singaphendulanga kahle kwezinye izindlela zokwelapha noma uma udinga umuthi onamandla wokulawula izimpawu zakho.
Lo muthi uvame ukunikezwa ngalezi zimo, ngasinye sidinga ukuqapha ngokucophelela nezinhlelo zokwelapha ezenziwe ngabanye:
Umhlinzeki wakho wezempilo uzoqaphela ukuthi lo muthi ulungele isimo sakho esithile ngokusekelwe ezimpawini zakho, umlando wezokwelapha, nokuthi uphendule kanjani ekwelashweni kwangaphambilini. Umgomo uhlala ukukusiza ukuthi uzuze izinga elingcono lempilo ngenkathi ulawula noma yiziphi izingozi ezingaba khona.
I-Adalimumab-ryvk isebenza ngokuvimba iphrotheni ebizwa ngokuthi i-tumor necrosis factor-alpha (TNF-alpha) edlala indima ebalulekile ekubangeleni ukuvuvukala emzimbeni wakho wonke. Uma unesimo se-autoimmune, umzimba wakho ukhiqiza le phrotheni eningi kakhulu, okuholela ezimpawini ezibuhlungu ozizwayo.
Cabanga nge-TNF-alpha njengomqaphi wezokuphepha oqophile kakhulu emzimbeni wakho ohlasela izicubu ezinempilo ngephutha. Lo muthi usebenza njengomphathi onomusa, etshela lowo mqaphi ukuthi azole futhi ayeke ukubangela ukuvuvukala okungadingekile.
Lokhu kuthathwa njengomuthi oqinile ngoba ucindezela ingxenye yamasosha akho omzimba. Ngenkathi lokhu kusiza ukulawula isimo sakho sokuzivikela komzimba, futhi kusho ukuthi umzimba wakho ungase ube nobunzima bokulwa nezifo. Udokotela wakho uzokuqapha eduze ukuze alinganisele izinzuzo zokunciphisa ukuvuvukala nesidingo sokugcina amasosha akho omzimba esebenza kahle ngokwanele ukukuvikela.
Umuthi ngokuvamile uthatha amasonto amaningana kuya ezinyangeni ukukhombisa umphumela wawo ogcwele. Iziguli eziningi zibona ukuthuthuka okuthile emasontweni ambalwa okuqala, kodwa kungase kuthathe izinyanga ezintathu ukuzwa izinzuzo eziphezulu.
I-Adalimumab-ryvk inikezwa njenge-subcutaneous injection, okusho ukuthi ifakwa ngaphansi kwesikhumba sakho usebenzisa ipeni noma isirinji elizaliswe ngaphambili. Iziguli eziningi zithola umjovo wazo wokuqala ehhovisi likadokotela, lapho uzofunda khona indlela efanele yokuzenzela imijovo yakho ekhaya.
Uhlelo lokulinganisa olujwayelekile luyahlukahluka ngokuya ngesimo sakho, kodwa iziguli eziningi zifaka umuthi njalo ngemva kwamasonto amabili. Udokotela wakho uzonquma isikhathi esiqondile kanye nomthamo ngokuya ngezidingo zakho ezithile nokuthi usabela kanjani ekwelashweni.
Nakhu okudingeka ukwazi ngokuthatha umuthi wakho ngendlela efanele:
Akudingeki ukuthi uthathe lo muthi nokudla, kodwa kubalulekile ukulandela imiyalelo kadokotela wakho ngqo. Iziguli eziningi zithola kuwusizo ukusetha izikhumbuzi ocingweni lwazo ukuqinisekisa ukuthi aziphuthelwa imithamo.
Ubude bokwelashwa nge-adalimumab-ryvk buhlukahluka kakhulu kumuntu nomuntu futhi kuncike esimweni sakho esithile nokuthi usabela kanjani emuthini. Iziguli eziningi zithatha lo muthi izinyanga noma iminyaka ukuze zigcine ukulawula isimo sazo sokuzivikela emzimbeni.
Udokotela wakho uzohlola njalo inqubekela phambili yakho ngokuhlolwa kwegazi, ukuhlolwa komzimba, kanye nezingxoxo mayelana nezimpawu zakho. Uma umuthi usebenza kahle futhi ungaqali ukuba nemiphumela emibi, ungaqhubeka nokwelashwa isikhathi eside ukuvimbela ukuqubuka kwesimo sakho.
Ezinye iziguli zingakwazi ukunciphisa imvamisa yazo yokulinganisa noma ziyeke umuthi ngokuphelele uma isimo sazo singena ekuxoleleni. Kodwa-ke, lesi sinqumo kufanele senziwe kuphela ngesiqondiso sikadokotela wakho, njengoba ukuyeka ngokushesha kungaholela ekubuyeni kwezimpawu.
Ukuqapha njalo kubalulekile kuyo yonke inkathi yokwelashwa kwakho. Ithimba lakho lezempilo lizobheka izimpawu zokuthi umuthi uyasebenza, lihlole imiphumela emibi, futhi lilungise uhlelo lwakho lokwelashwa njengoba kudingeka ukuqinisekisa ukuthi uthola imiphumela engcono kakhulu.
Njengayo yonke imithi, i-adalimumab-ryvk ingabangela imiphumela emibi, nakuba kungewona wonke umuntu oyitholayo. Imiphumela eminingi emibi imnene futhi iyalawuleka, kodwa kubalulekile ukwazi ukuthi yini okufanele uyibheke ukuze ukwazi ukufuna usizo uma kudingeka.
Imiphumela emibi evame kakhulu ivamise ukuba mnene futhi ithambekele ekuthuthukiseni njengoba umzimba wakho ujwayela umuthi:
Imiphumela emibi engathi sína ingenzeka kodwa ayivamile. Lokhu kudinga ukunakekelwa kwezempilo ngokushesha futhi kufaka phakathi izifo ezinzima, ukusabela komzimba, noma izimpawu zezinkinga zesibindi. Udokotela wakho uzoxoxa nawe ngalezi zingozi futhi akunikeze imiyalelo ecacile yokuthi nini ukufuna ukunakekelwa okuphuthumayo.
Ezinye iziguli zingase zibe nemiphumela emibi engavamile kodwa engathi sína njengozi elandayo lomdlavuza othile, izifo ezinzima, noma ukuvuselelwa kwe-hepatitis B. Ngenkathi lokhu kuzwakala kuyesabisa, khumbula ukuthi udokotela wakho ukale ngokucophelela izinzuzo ngokumelene nalezi zingozi ngaphambi kokunquma lo muthi.
Ukuhlolwa kwegazi njalo nokuhlolwa kusiza ithimba lakho lezempilo ukuthi libambe noma yiziphi izinkinga ezingaba khona ekuqaleni. Iziguli eziningi zikubekezelela kahle lo muthi futhi zithola ukuthi izinzuzo zokunciphisa ukuvuvukala nokuthuthukisa izimpawu zidlula kakhulu izingozi.
I-Adalimumab-ryvk ayifanele wonke umuntu, futhi udokotela wakho uzobuyekeza ngokucophelela umlando wakho wezokwelapha ngaphambi kokunquma lo muthi. Ezinye izimo zezempilo noma izimo zenza lo muthi ungaphephile noma ungasebenzi kahle.
Udktela wakho cishe uzoncoma ukwelashwa okuhlukile uma unezinye zalezi zimo:
Udktela wakho angase futhi aqhubeke ngokucophelela uma unesifo sikashukela, isifo sesibindi, noma umlando wezifo eziphindaphindayo. Lezi zimo akudingeki zikuvimbele ukuthatha umuthi, kodwa zidinga ukuqapha okuseduze futhi mhlawumbe nezinyathelo zokuphepha ezengeziwe.
Ubudala bungaba yisici futhi, njengoba abadala bengase babe nengozi enkulu yokutheleleka nezinye izinkinga. Ithimba lakho lokunakekelwa kwezempilo lizocabangela impilo yakho yonke, eminye imithi oyithathayo, kanye nezici zakho eziyingozi ngamanye lapho kunqunywa ukuthi lo muthi ukufanele yini.
I-Adalimumab-ryvk itholakala ngaphansi kwegama lomkhiqizo elithi Cyltezo e-United States. Lo muthi we-biosimilar wathuthukiswa yi-Boehringer Ingelheim futhi wagunyazwa yi-FDA njengenye indlela engabizi kakhulu kunomuthi wokuqala we-adalimumab.
Ungase futhi uhlangane ne-adalimumab yasekuqaleni ngaphansi kwegama lomkhiqizo elithi Humira, elitholakale isikhathi eside futhi yilokho i-adalimumab-ryvk eklanyelwe ukukulingisa. Yomibili imithi isebenza ngendlela efanayo futhi inokusebenza okufanayo, kodwa inguqulo ye-biosimilar ivame ukubiza kancane.
Ikhambi lakho lingase lithathe omunye umkhiqizo we-adalimumab ngomunye, ngendlela efana nokuthi imithi ejwayelekile isebenza kanjani. Uma unokukhathazeka ngokushintsha phakathi kwezinhlobo ezihlukene, xoxa ngalokhu nodokotela wakho noma usokhemisi ukuze uqinisekise ukuthi uzizwa ukhululekile nganoma yiziphi izinguquko ekwelashweni kwakho.
Uma i-adalimumab-ryvk ingeyona inketho efanele kuwe, ezinye izinketho zokwelapha ziyatholakala zezimo ze-autoimmune. Udokotela wakho angakusiza ukuthi uhlole lezi ezinye izindlela ngokusekelwe esimweni sakho esithile, umlando wezokwelapha, kanye nemigomo yokwelashwa.
Eminye imithi ye-TNF blocker isebenza ngendlela efana ne-adalimumab-ryvk futhi ingase ibe ezinye izindlela ezifanele:
Imithi ye-non-TNF biologic iqondisa izingxenye ezihlukene zesimiso somzimba sokuzivikela futhi ingase isebenze lapho ama-TNF blockers engasebenzi:
Imithi yendabuko yokuguqula izifo efana ne-methotrexate, sulfasalazine, noma i-hydroxychloroquine ihlala iyizinketho ezibalulekile, ikakhulukazi ezigulini ezikhetha imithi yomlomo noma ezidinga ukucindezelwa okuncane kwesistimu yokuzivikela. Udokotela wakho uzokusiza ukuthi ulinganise izinzuzo nobubi benketho ngayinye.
I-Adalimumab-ryvk ne-Humira empeleni ziyimithi efanayo mayelana nokusebenza nokuphepha. Zombili ziqukethe isithako esifanayo esisebenzayo (i-adalimumab) futhi zisebenza ngendlela efanayo emzimbeni wakho ukunciphisa ukuvuvukala nokulawula izimo ze-autoimmune.
Umehluko omkhulu ukubiza nezinto ezitholakalayo. I-Adalimumab-ryvk, njenge-biosimilar, ngokuvamile ibiza kancane kune-Humira yasekuqaleni, okwenza ukwelashwa kube ngcono kubantu abaningi. Lokhu kungabaluleka ikakhulukazi uma ukhokha ngaphandle kwesikhwama noma unezinkokhelo eziphezulu.
Izifundo zomtholampilo zikhombisile ukuthi imithi ye-biosimilar efana ne-adalimumab-ryvk ikhiqiza imiphumela efanayo yokwelapha njengomuthi wokuqala. I-FDA idinga ama-biosimilars ukuthi ahlangabezane nezindinganiso eziqinile ezibonisa ukuthi asebenza kahle njengomuthi wokuqala.
Umshwalense wakho ungase uthinte ukuthi iyiphi inguqulo oyitholayo, njengoba izinhlelo eziningi zomshwalense zikhetha izinketho ze-biosimilar ezibiza kancane. Yomibili imithi inohlu olufanayo lwemiphumela emibi kanye nezidingo zokuqapha, ngakho ukushintsha phakathi kwazo akufanele kuthinte uhlelo lwakho lokwelashwa ngendlela enkulu.
I-Adalimumab-ryvk ingasetshenziswa kubantu abanesifo sikashukela, kodwa idinga ukuqapha okucophelelayo nokusebenzisana phakathi kwabadokotela bakho. Isifo sikashukela singakhuphula ingozi yakho yokutheleleka, futhi njengoba lo muthi ucindezela amasosha akho omzimba, ithimba lakho lezempilo lizokubhekisisa nganoma yiziphi izimpawu zokutheleleka.
Ukulawulwa kwakho ushukela wegazi kuba kubaluleke nakakhulu ngenkathi uthatha lo muthi, njengoba izifo zingenza isifo sikashukela sibe nzima ukusilawula. Qiniseka ukuthi bonke odokotela bakho bayazazi zombili izimo ukuze bakwazi ukusebenzisana ukuze bakugcine uphilile.
Uma ngabe uzifake ngengozi i-adalimumab-ryvk eningi kunaleyo ebekiwe, xhumana nodokotela wakho noma umhlinzeki wezempilo ngokushesha. Nakuba ukweqisa imithamo kungavamile ngalo muthi, ukuthatha okuningi kungakhuphula ingozi yakho yemiphumela emibi noma izifo.
Ungalindi ukubona ukuthi uzizwa ulungile yini - shayela udokotela wakho ngokushesha ukuze nixoxe ngalokho okwenzekile futhi uthole isiqondiso ngezinyathelo ezilandelayo. Bangase bafune ukukuqapha eduze noma balungise isimiso sakho sokulinganisa ukuze kubalwe umuthi owengeziwe.
Uma udlula umthamo we-adalimumab-ryvk, yithathe ngokushesha lapho ukhumbula, bese uqhubeka nesimiso sakho sokulinganisa esivamile. Nokho, uma sekuseduze isikhathi somthamo wakho olandelayo obekiwe, weqa umthamo odlulisiwe futhi ungaqali ukuthatha imithi emibili.
Xhumana nodokotela wakho uma ungaqiniseki ngesikhathi noma uma udlule imithamo eminingi. Bangakusiza ukuthi ubuyele emgqeni ngesimiso sakho sokwelashwa futhi baqinisekise ukuthi ugcina amazinga emithi afanele emzimbeni wakho.
Ungalokothi uyeke ukuthatha i-adalimumab-ryvk ngaphandle kokubonisana nodokotela wakho kuqala, ngisho noma uzizwa ungcono kakhulu. Ukuyeka kungazelelwe kungaholela ekuqubukeni kwesimo sakho sokuzivikela emzimbeni, okungase kube kubi kunezimpawu zakho zokuqala.
Udokotela wakho uzokusiza ukuthi unqume isikhathi esifanele sokunciphisa noma ukuyeka imithi yakho ngokusekelwe esimweni sakho, ukuthi usunesikhathi esingakanani ekuxolelweni, nezinye izinto. Ezinye iziguli zidinga ukuqhubeka nokwelashwa isikhathi eside ukuze zigcine impilo yazo, kanti ezinye zingase zikwazi ukuyeka noma ukunciphisa ukulinganisa kwazo ngaphansi kokuqondiswa kwezokwelapha.
Kufanele ugweme imigomo ebukhoma ngenkathi uthatha i-adalimumab-ryvk ngoba uhlelo lwakho lokuzivikela emzimbeni olucindezelwe lungase lungakwazi ukuzisingatha ngokuphepha. Nokho, imigomo engasebenzi (njengemijovo yomkhuhlane) ngokuvamile iphephile futhi iyatuswa ukukusiza ukuthi uzivikele ezifweni.
Xoxa nodokotela wakho ngaphambi kokuthola imigomo, futhi qiniseka ukuthi ubuyekeza imigomo yakho ngaphambi kokuqala ukwelashwa uma kungenzeka. Ithimba lakho lokunakekelwa kwezempilo lingakunikeza uhlu lwemigomo ephephile futhi likusize ukuthi uhlale uvikelekile ezifweni ezingavikeleka ngenkathi uphatha isimo sakho sokuzivikela komzimba.
Get clear medical guidance
on symptoms, medications, and lab reports.